1. Home
  2. RNAC vs LMNR Comparison

RNAC vs LMNR Comparison

Compare RNAC & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAC
  • LMNR
  • Stock Information
  • Founded
  • RNAC 2007
  • LMNR 1893
  • Country
  • RNAC United States
  • LMNR United States
  • Employees
  • RNAC N/A
  • LMNR N/A
  • Industry
  • RNAC Biotechnology: Pharmaceutical Preparations
  • LMNR Farming/Seeds/Milling
  • Sector
  • RNAC Health Care
  • LMNR Consumer Staples
  • Exchange
  • RNAC Nasdaq
  • LMNR Nasdaq
  • Market Cap
  • RNAC 472.7M
  • LMNR 486.1M
  • IPO Year
  • RNAC 2016
  • LMNR N/A
  • Fundamental
  • Price
  • RNAC $17.33
  • LMNR $26.39
  • Analyst Decision
  • RNAC Strong Buy
  • LMNR Buy
  • Analyst Count
  • RNAC 7
  • LMNR 2
  • Target Price
  • RNAC $40.80
  • LMNR $24.00
  • AVG Volume (30 Days)
  • RNAC 107.5K
  • LMNR 40.2K
  • Earning Date
  • RNAC 11-07-2024
  • LMNR 12-19-2024
  • Dividend Yield
  • RNAC N/A
  • LMNR 1.14%
  • EPS Growth
  • RNAC N/A
  • LMNR N/A
  • EPS
  • RNAC N/A
  • LMNR 0.29
  • Revenue
  • RNAC $47,938,000.00
  • LMNR $189,075,000.00
  • Revenue This Year
  • RNAC $69.22
  • LMNR $7.75
  • Revenue Next Year
  • RNAC N/A
  • LMNR $16.50
  • P/E Ratio
  • RNAC N/A
  • LMNR $90.29
  • Revenue Growth
  • RNAC N/A
  • LMNR 6.15
  • 52 Week Low
  • RNAC $11.67
  • LMNR $14.73
  • 52 Week High
  • RNAC $42.60
  • LMNR $29.22
  • Technical
  • Relative Strength Index (RSI)
  • RNAC 39.04
  • LMNR 46.71
  • Support Level
  • RNAC $15.50
  • LMNR $25.75
  • Resistance Level
  • RNAC $22.20
  • LMNR $29.22
  • Average True Range (ATR)
  • RNAC 1.65
  • LMNR 0.85
  • MACD
  • RNAC -0.56
  • LMNR -0.11
  • Stochastic Oscillator
  • RNAC 24.43
  • LMNR 29.25

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

About LMNR Limoneira Co

Limoneira Co is an agribusiness company. The company's operating segments include Fresh Lemons; Lemon Packing; Avocados and Other Agribusiness. It generates maximum revenue from the Fresh Lemons segment.

Share on Social Networks: